Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
AstraZeneca pens $5.3B pact with CSPC to develop oral drugs
AstraZeneca has returned to recent collaborator CSPC with $110 million in upfront cash to find new oral drugs for a range of chronic diseases.
James Waldron
Jun 13, 2025 5:56am
Sponsored
Why Puerto Rico is the smart choice for bioscience reshoring
Jun 9, 2025 8:00am
How 'overenthusiasm' led to Big Pharma's risky $6B TIGIT gamble
Jun 13, 2025 8:00am
Sponsored
Learn How to Reduce Costly Study Delays
Jun 2, 2025 8:00am
Astellas offers lab space to help Japanese biotechs 'go global'
Jun 13, 2025 4:41am
Sanofi vaccine vet vaults to GSK—Chutes & Ladders
Jun 13, 2025 8:30am
More News
Inside Fierce Medtech's Fierce 15
Jun 13, 2025 8:47am
ADC Therapeutics shutters UK R&D site, lays off 30% of staff
Jun 12, 2025 3:00pm
Exosuit maker Wandercraft raises $75M alongside Renault tie-up
Jun 12, 2025 2:29pm
Fierce Biotech Layoff Tracker 2025: ADC Tx, Vertex & more
Jun 12, 2025 1:00pm
